Home » VectorVest » Buy CYBG #CYBG says VectorVest. Despite substantial growth since April, the stock remains materially undervalued.

Buy CYBG #CYBG says VectorVest. Despite substantial growth since April, the stock remains materially undervalued.

UK- based CYBG Plc (CYBG.L) is the holding company for CYB Investments Limited (CYBI) and Clydesdale Bank PLC (Clydesdale Bank). The Company owns National Australia Bank Limited’s Clydesdale and Yorkshire Bank operations (the Clydesdale Bank business). Clydesdale Bank provides banking services to UK SME’s, with products and services including mortgages, current accounts, deposits, term lending, personal loans, working capital solutions, overdrafts, credit cards and payment and transaction services. Clydesdale Bank consists of approximately 120 Clydesdale Bank-branded branches and approximately 150 Yorkshire Bank-branded branches.

Examine this trading opportunity and a host of other similar stocks. A single payment of £5.95 gives access to the VectorVest Risk Free 30-day trial. More here

On August 1st 2017, CYBG said trading for the 3 months to 30 June 2017 had been in line with expectations, with continued delivery against the Group’s strategic targets and objectives. CYBG confirmed a continued robust capital position, with a CET1 ratio of 12.4%, comfortably within target range (12-13%). In addition agreement had been reached to close the Group’s defined benefit pension scheme to future benefit accrual, delivering a substantial reduction in the scheme’s funding deficit. The CYBG efficiency programme also came in ahead of schedule, with underlying FY operating costs expected in below £680m, ahead of previous guidance of £690-700m. CEO David Duffy said the board remained confident that the medium term strategy outlined at the capital markets day in September 2016 “will differentiate us from our competitors and deliver our FY19 targets as we seek to build a better bank for our customers and staff and improve returns for our shareholders.”

April 2017 triggered a GRT (Earnings Growth Rate) earnings increase for CYBG across the VectorVest stock analysis and portfolio management platform. Despite the stock briefly dipping from 285p to 260p, the GRT chart has continued to build over the summer. GRT reflects a company’s one to three year forecasted earnings growth rate in percent per year, and despite trading today at 313p, CYBG still logs a GRT of 42%, which VectorVest considers to be excellent. Despite the increase since April, CYBG still trades at just 313p, leaving the stock materially undervalued against our target of 462p.

The chart of CYBG.L is shown above in my normal format. Earnings per share (EPS) is growing smoothly over the last year and that’s driving the share price higher. EPS has trebled over the last year. Technically the chart is strong with the share breaking through a 52 week high at the end of September 2017. CYBG.L is ona BUY recommendation on VectorVest.

Although many banks and financials stocks have endured a torrid time since the credit crunch, some of the smaller market constituents offer greater flexibility and significant upside potential. Having triggered a substantial earnings upgrade metric on the VectorVest platform, CYBG is firmly in this category, particularly on account of operating cost reductions and reduced pension liabilities. Shares have already delivered substantial growth since the April flag, but in the view of VectorVest remain materially undervalued against our 462p valuation.


Dr David Paul

November 1 2017

Readers can examine trading opportunities on CYBG and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-day trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view.


VectorVest Unisearch

On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 5 week trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email: support@VectorVest.com

Leave a comment

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.